AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development10,420.73210,546.28715,111.686
Selling General and Administrative5,144.2246,536.0679,055.885
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-15,564.956-17,082.354-24,167.571
Income from Continuing Operations
Total Other Income/Expenses Net-36,326.989-1,037.92259.853
Earnings Before Interest and Taxes-51,891.945-19,163.629-24,107.718
Interest Expense---
Income Before Tax-51,891.945-19,163.629-24,107.718
Income Tax Expense---
Minority Interest--927.83
Net Income From Continuing Ops-51,891.945-19,163.629-24,107.718
Non-recurring Events
Discontinued Operations---9,606.199
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-51,891.945-19,163.629-32,010.242
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-51,891.945-19,163.629-32,010.242